All Costs, No Benefits

How TRIPS-plus intellectual property rules in the US-Jordan FTA affect access to medicines

Briefing Paper

Published: Apr 03, 2007

Publication Summary

Since enactment of the TRIPS (Trade Related Aspects of Intellectual Property Rights) Agreement in 1995, the US has imposed progressively higher levels of intellectual property protection on developing countries, which undermines access to affordable medicines. The US-Jordan free trade agreement introduced a rigid framework of such rules and medicine prices in Jordan have increased 20 per cent since 2001.

Oxfam_US_Jordan_FTA_Briefing.pdf (340.8 kB)
Document Actions
Filed under:
Questions?

Students and researchers

Please contact research@oxfamamerica.org with questions and for help with any Oxfam research materials.

General inquiries

If you have a question or comment about any other Oxfam America publication, or would like to submit a letter to the Editor of OXFAMExchange Magazine, please contact editor@oxfamamerica.org.